
Clinicopathological Study of Triple Negative Breast Cancers
Author(s) -
Gunadala Ishitha,
Marie Therese Manipadam,
Selvamani Backianathan,
Raju Titus Chacko,
Deepak Thomas Abraham,
Paul Jacob
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/20475.8539
Subject(s) - basal (medicine) , immunohistochemistry , triple negative , triple negative breast cancer , breast cancer , medicine , pathology , oncology , cancer , insulin
Triple Negative Breast Cancers (TNBC) are a subset of breast cancers which are composed of different molecular subtypes. The most common is the basal like subtype, which has an adverse prognosis and limited treatment options.